Abeona Therapeutics, Inc. (ABEO)
5.105
+0.08
(+1.49%)
USD |
NASDAQ |
Oct 05, 16:00
5.105
0.00 (0.00%)
After-Hours: 20:00
Abeona Therapeutics Price : 5.105 for Oct. 5, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 5.09 | 5.105 | 4.985 | 5.03 | 1.214M |
| Oct 01, 2026 | 5.22 | 5.25 | 4.985 | 5.01 | 1.476M |
| Sep 30, 2026 | 5.16 | 5.33 | 5.10 | 5.25 | 1.131M |
| Sep 29, 2026 | 5.30 | 5.30 | 5.11 | 5.16 | 1.254M |
| Sep 28, 2026 | 5.35 | 5.40 | 5.19 | 5.29 | 872884.0 |
| Sep 25, 2026 | 5.45 | 5.475 | 5.335 | 5.40 | 720708.0 |
| Sep 24, 2026 | 5.59 | 5.59 | 5.38 | 5.43 | 852416.0 |
| Sep 23, 2026 | 5.82 | 5.90 | 5.52 | 5.53 | 1.190M |
| Sep 22, 2026 | 5.71 | 5.865 | 5.69 | 5.82 | 1.020M |
| Sep 21, 2026 | 5.66 | 5.68 | 5.59 | 5.67 | 1.013M |
| Sep 18, 2026 | 5.82 | 5.84 | 5.525 | 5.57 | 2.772M |
| Sep 17, 2026 | 5.69 | 5.74 | 5.37 | 5.59 | 3.463M |
| Sep 16, 2026 | 5.51 | 5.549 | 5.215 | 5.37 | 1.903M |
| Sep 15, 2026 | 5.42 | 5.56 | 5.32 | 5.47 | 1.935M |
| Sep 14, 2026 | 5.41 | 5.525 | 5.37 | 5.43 | 1.416M |
| Sep 11, 2026 | 5.55 | 5.66 | 5.40 | 5.415 | 1.598M |
| Sep 10, 2026 | 5.70 | 5.70 | 5.31 | 5.48 | 2.285M |
| Sep 09, 2026 | 5.81 | 5.907 | 5.70 | 5.79 | 1.783M |
| Sep 08, 2026 | 5.935 | 5.995 | 5.81 | 5.85 | 872572.0 |
| Sep 04, 2026 | 5.89 | 6.02 | 5.85 | 6.00 | 866505.0 |
| Sep 03, 2026 | 5.99 | 6.03 | 5.855 | 5.93 | 862020.0 |
| Sep 02, 2026 | 5.98 | 6.10 | 5.855 | 5.95 | 1.089M |
| Sep 01, 2026 | 5.80 | 5.995 | 5.79 | 5.98 | 683833.0 |
| Aug 31, 2026 | 5.905 | 5.92 | 5.78 | 5.85 | 993556.0 |
| Aug 28, 2026 | 5.99 | 6.035 | 5.88 | 5.92 | 912890.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Ultragenyx Pharmaceutical, Inc. | 14.52 |
| ACADIA Pharmaceuticals, Inc. | 20.10 |
| Alnylam Pharmaceuticals, Inc. | 219.91 |
| Savara, Inc. | 4.785 |
| Vericel Corp. | 41.11 |
Price Related Metrics
| PS Ratio | 11.15 |
| Price to Book Value | 2.281 |
| Earnings Yield | -21.99% |
| Market Cap | 292.14M |